ChloroquineV1, PascalFrancis, Curation, bibRecord, 000082

Vitamin D, calcium, and sarcoidosis

Identifieur interne : 000082 ( PascalFrancis/Curation ); précédent : 000081; suivant : 000083

Vitamin D, calcium, and sarcoidosis

Auteurs : O. P. Sharma [États-Unis]

Source :

Chest [ 0012-3692 ] ; 1996.

RBID : Pascal:96-0152443

Descripteurs français

Pascal (Inist)
- Sarcoïdose, Homme, Calcium, Vitamine D, Métabolisme, Macrophage, Hypercalcémie, Alvéole pulmonaire, Kétoconazole, Elément minéral.
Wicri :
- topic : Homme, Calcium.

English descriptors

KwdEn :
- Calcium, Human, Hypercalcemia, Inorganic element, Macrophage, Metabolism, Pulmonary alveolus, Sarcoidosis, Vitamin D.

Abstract

Hypercalcemia occurs in about 10% of the patients with sarcoidosis ; hypercalciuria is about three times more frequent. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH) ₂-D₃ (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroqune, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.

A01	`01`	`1`		`@0 0012-3692`
A02	`01`			`@0 CHETBF`
A03		`1`		`@0 Chest`
A05				`@2 109`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Vitamin D, calcium, and sarcoidosis`
A11	`01`	`1`		`@1 SHARMA (O. P.)`
A14	`01`			`@1 USC school medicine, dep. pulmonary critical care medicine @2 Los Angeles CA @3 USA`
A20				`@1 535-539`
A21				`@1 1996`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 7627 @5 354000055184290430`
A44				`@0 0000`
A45				`@0 78 ref.`
A47	`01`	`1`		`@0 96-0152443`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Chest`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Hypercalcemia occurs in about 10% of the patients with sarcoidosis ; hypercalciuria is about three times more frequent. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH) ₂-D₃ (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroqune, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.
C02	`01`	`X`		`@0 002B07`
C03	`01`	`X`	`FRE`	`@0 Sarcoïdose @5 01`
C03	`01`	`X`	`ENG`	`@0 Sarcoidosis @5 01`
C03	`01`	`X`	`SPA`	`@0 Sarcoidosis @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Calcium @2 NC @2 FR @5 03`
C03	`03`	`X`	`ENG`	`@0 Calcium @2 NC @2 FR @5 03`
C03	`03`	`X`	`GER`	`@0 Calcium @2 NC @2 FR @5 03`
C03	`03`	`X`	`SPA`	`@0 Calcio @2 NC @2 FR @5 03`
C03	`04`	`X`	`FRE`	`@0 Vitamine D @2 NK @2 FR @5 04`
C03	`04`	`X`	`ENG`	`@0 Vitamin D @2 NK @2 FR @5 04`
C03	`04`	`X`	`SPA`	`@0 Vitamina D @2 NK @2 FR @5 04`
C03	`05`	`X`	`FRE`	`@0 Métabolisme @5 05`
C03	`05`	`X`	`ENG`	`@0 Metabolism @5 05`
C03	`05`	`X`	`SPA`	`@0 Metabolismo @5 05`
C03	`06`	`X`	`FRE`	`@0 Macrophage @5 06`
C03	`06`	`X`	`ENG`	`@0 Macrophage @5 06`
C03	`06`	`X`	`SPA`	`@0 Macrófago @5 06`
C03	`07`	`X`	`FRE`	`@0 Hypercalcémie @5 07`
C03	`07`	`X`	`ENG`	`@0 Hypercalcemia @5 07`
C03	`07`	`X`	`SPA`	`@0 Hipercalcemia @5 07`
C03	`08`	`X`	`FRE`	`@0 Alvéole pulmonaire @5 08`
C03	`08`	`X`	`ENG`	`@0 Pulmonary alveolus @5 08`
C03	`08`	`X`	`SPA`	`@0 Alvéolo pulmonar @5 08`
C03	`09`	`X`	`FRE`	`@0 Kétoconazole @2 NK @2 FR @5 09`
C03	`10`	`X`	`FRE`	`@0 Elément minéral @5 29`
C03	`10`	`X`	`ENG`	`@0 Inorganic element @5 29`
C03	`10`	`X`	`SPA`	`@0 Elemento inorgánico @5 29`
C07	`01`	`X`	`FRE`	`@0 Maladie système @5 37`
C07	`01`	`X`	`ENG`	`@0 Systemic disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Enfermedad sistémica @5 37`
C07	`02`	`X`	`FRE`	`@0 Trouble métabolisme @5 53`
C07	`02`	`X`	`ENG`	`@0 Metabolic disorder @5 53`
C07	`02`	`X`	`SPA`	`@0 Trastorno metabolismo @5 53`
C07	`03`	`X`	`FRE`	`@0 Trouble équilibre hydroélectrolytique @5 54`
C07	`03`	`X`	`ENG`	`@0 Hydroelectrolytic balance disorder @5 54`
C07	`03`	`X`	`SPA`	`@0 Trastorno equilibrio hidroelectrolítico @5 54`
N21				`@1 099`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000088

Links to Exploration step

Pascal:96-0152443

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Vitamin D, calcium, and sarcoidosis</title>
<author><name sortKey="Sharma, O P" sort="Sharma, O P" uniqKey="Sharma O" first="O. P." last="Sharma">O. P. Sharma</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>USC school medicine, dep. pulmonary critical care medicine</s1>
<s2>Los Angeles CA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0152443</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0152443 INIST</idno>
<idno type="RBID">Pascal:96-0152443</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000088</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000082</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Vitamin D, calcium, and sarcoidosis</title>
<author><name sortKey="Sharma, O P" sort="Sharma, O P" uniqKey="Sharma O" first="O. P." last="Sharma">O. P. Sharma</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>USC school medicine, dep. pulmonary critical care medicine</s1>
<s2>Los Angeles CA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Chest</title>
<title level="j" type="abbreviated">Chest</title>
<idno type="ISSN">0012-3692</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Chest</title>
<title level="j" type="abbreviated">Chest</title>
<idno type="ISSN">0012-3692</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Calcium</term>
<term>Human</term>
<term>Hypercalcemia</term>
<term>Inorganic element</term>
<term>Macrophage</term>
<term>Metabolism</term>
<term>Pulmonary alveolus</term>
<term>Sarcoidosis</term>
<term>Vitamin D</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Sarcoïdose</term>
<term>Homme</term>
<term>Calcium</term>
<term>Vitamine D</term>
<term>Métabolisme</term>
<term>Macrophage</term>
<term>Hypercalcémie</term>
<term>Alvéole pulmonaire</term>
<term>Kétoconazole</term>
<term>Elément minéral</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Calcium</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hypercalcemia occurs in about 10% of the patients with sarcoidosis ; hypercalciuria is about three times more frequent. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH) <sub>2</sub>
-D<sub>3</sub>
 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroqune, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0012-3692</s0>
</fA01>
<fA02 i1="01"><s0>CHETBF</s0>
</fA02>
<fA03 i2="1"><s0>Chest</s0>
</fA03>
<fA05><s2>109</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Vitamin D, calcium, and sarcoidosis</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SHARMA (O. P.)</s1>
</fA11>
<fA14 i1="01"><s1>USC school medicine, dep. pulmonary critical care medicine</s1>
<s2>Los Angeles CA</s2>
<s3>USA</s3>
</fA14>
<fA20><s1>535-539</s1>
</fA20>
<fA21><s1>1996</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>7627</s2>
<s5>354000055184290430</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>78 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>96-0152443</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Chest</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Hypercalcemia occurs in about 10% of the patients with sarcoidosis ; hypercalciuria is about three times more frequent. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH) <sub>2</sub>
-D<sub>3</sub>
 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroqune, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B07</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Sarcoïdose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Sarcoidosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sarcoidosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="GER"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Calcio</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Vitamine D</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Vitamin D</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vitamina D</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Métabolisme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Metabolism</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Metabolismo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Macrophage</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Macrophage</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Macrófago</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Hypercalcémie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Hypercalcemia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hipercalcemia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Alvéole pulmonaire</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Pulmonary alveolus</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Alvéolo pulmonar</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Kétoconazole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Elément minéral</s0>
<s5>29</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Inorganic element</s0>
<s5>29</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Elemento inorgánico</s0>
<s5>29</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Maladie système</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Systemic disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad sistémica</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Trouble métabolisme</s0>
<s5>53</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Metabolic disorder</s0>
<s5>53</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Trastorno metabolismo</s0>
<s5>53</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Trouble équilibre hydroélectrolytique</s0>
<s5>54</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Hydroelectrolytic balance disorder</s0>
<s5>54</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Trastorno equilibrio hidroelectrolítico</s0>
<s5>54</s5>
</fC07>
<fN21><s1>099</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000082 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000082 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:96-0152443
   |texte=   Vitamin D, calcium, and sarcoidosis
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Vitamin D, calcium, and sarcoidosis

Vitamin D, calcium, and sarcoidosis

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri